| Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer (NCT06959082) | VSPharmTech Co.,Ltd. | 2026-06-01 |
| Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial) (NCT07582458) | Radboud University Medical Center | 2026-06-01 |
| VA Consolidation in Intermediate-Risk AML (NCT07672262) | The First Affiliated Hospital of Soochow University | 2026-06-01 |
| nVNS, CBD, and SoC for Persistent Post-Traumatic Headache (NCT07624279) | American Society of Pain and Neuroscience, Inc. | 2026-06-01 |
| Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee (NCT07550231) | Addpharma Inc. | 2026-06-01 |
| Trial to Evaluate the Effects of Naltrexone in Nonsuicidal Self-injury (NCT06622239) | Seoul National University Hospital | 2026-06-01 |
| Engineered Immune Effectors Against Cervical Cancer (NCT03362619) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| GD2/CD70 Bi-specific CAR-T Cell Therapy (NCT05438368) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Nemtabrutinib, Bortezomib, and Rituximab for WM (NCT07464210) | Seoul National University Hospital | 2026-06-01 |
| SCARFREE-001: Verteporfin for Scar Prevention (NCT07488988) | Odense University Hospital | 2026-06-01 |
| Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes (NCT07557914) | Haibo Shao | 2026-06-01 |
| Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer (NCT07610720) | Sun Yat-sen University | 2026-06-01 |
| Efficacy of Ivermectin in the Treatment of Plane Warts (NCT07710638) | Al-Azhar University | 2026-06-01 |
| A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR) (NCT07557446) | Angitia Biopharmaceuticals Guangzhou Limited | 2026-06-01 |
| Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants (NCT04614714) | University of California, Davis | 2026-06-01 |
| Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma (NCT07680569) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2026-06-01 |
| Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia (NCT07384702) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2026-06-01 |
| Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma (NCT07244978) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-06-01 |
| Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger (NCT07569289) | Bedaya Hospital | 2026-06-01 |
| Disitamab Vedotin Combined With Sintilimab and Multimodal Radiotherapy for HER2-Positive Advanced Gastric Cancer After Second-Line Treatment Failure: A Prospective, Single-Arm Phase II Clinical Trial (NCT07490990) | West China Hospital | 2026-06-01 |
| Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer (NCT07630103) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-06-01 |
| A Clinical Study of SHR-1701 Combined With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Siewert Type II Adenocarcinoma of the Esophagogastric Junction (NCT07607210) | Hebei Medical University Fourth Hospital | 2026-06-01 |
| Staph Nasal Decolonization to Improve Function and Feeding (NCT07524894) | David Palma | 2026-06-01 |
| Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis (NCT07595900) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-06-01 |
| Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema (NCT07592273) | AbbVie | 2026-06-01 |
| Impact of Standardization on Outcomes Following Cervical Ripening (NCT07576881) | Indiana University | 2026-06-01 |
| Addressing Treatment Nonresponders (NCT05921227) | University of Arizona | 2026-06-01 |
| ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation (NCT07015853) | Stephen Shiao | 2026-06-01 |
| 4SCAR-T Therapy Post CD19-targeted Immunotherapy (NCT04430530) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Complementary Herbal Approach to Rheumatoid Management Study (CHARMS) (NCT07627893) | Singapore General Hospital | 2026-06-01 |
| SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS (NCT07562568) | The First Affiliated Hospital of Soochow University | 2026-06-01 |
| SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS (NCT07575412) | The First Affiliated Hospital of Soochow University | 2026-06-01 |
| Luspatercept for CIA in AML (NCT07663864) | Guangdong Second Provincial General Hospital | 2026-06-01 |
| SMART Diets for MASLD (NCT07459504) | Michigan State University | 2026-06-01 |
| A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo (NCT07647237) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2026-06-01 |
| Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma (NCT07616141) | Eye & ENT Hospital of Fudan University | 2026-06-01 |
| Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With Resectable Borderline Pancreatic Ductal Adenocarcinoma. (NCT07616362) | Federation Francophone de Cancerologie Digestive | 2026-06-01 |
| Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage. (NCT07583147) | University Hospital, Toulouse | 2026-06-01 |
| This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC (NCT07723924) | Bausch Health Americas, Inc. | 2026-06-01 |
| Genicular Embolization Using Doxycycline Sclerotherapy (NCT07024654) | Campbell Clinic | 2026-06-01 |
| Effect of Guanxinning Tablet on Coronary Microcirculation After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction (NCT07621107) | Beijing Anzhen Hospital | 2026-06-01 |
| TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis (NCT06733519) | Tharimmune Inc | 2026-06-01 |
| Multi-CAR-T Cells Targeting B Cell Lymphomas (NCT04429438) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Dexmedetomidine for Invasive Ventilation In the NEOnate (NCT07493785) | Centre Hospitalier Intercommunal Creteil | 2026-06-01 |
| Trilaciclib Combined With Immunochemotherapy for R/M HNSCC (NCT07679997) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-06-01 |
| Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis (NCT04085159) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant (NCT07690761) | Bnai Zion Medical Center | 2026-06-01 |
| Rivastigmine for Antimuscarinic Delirium (NCT06382649) | Washington University School of Medicine | 2026-06-01 |
| Dexamethasone for Ureteral STent Symptoms (DUSTS) (NCT06930690) | The Methodist Hospital Research Institute | 2026-06-01 |
| Evaluation of Echothiophate in Pediatric Patients With Refractory Amblyopia (NCT07554131) | University of Oklahoma | 2026-06-01 |
| Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) (NCT07617324) | Chengdu Kangnuoxing Biopharma,Inc. | 2026-06-01 |
| Naturally Produced Cannabinoids for Neuroprotection From Concussion (NCT07715864) | University of Regina | 2026-06-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations (NCT07610798) | Shenzhen Ionova Life Sciences Co., Ltd. | 2026-06-01 |
| Pembrolizumab + MRGOO3 as Neoadjuvant in NPC (NCT07267338) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2026-06-01 |
| Lomustine Combined With Anlotinib as Interventional Therapy for Extensive-stage Small Cell Lung Cancer Resistant to Second-line and Above Treatment (NCT07632209) | Yayi He | 2026-06-01 |
| Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma (NCT03271632) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer (NCT07528768) | AntiCancer Research Jamaica | 2026-06-01 |
| H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC) (NCT07484139) | UNC Lineberger Comprehensive Cancer Center | 2026-06-01 |
| Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer (NCT07640932) | Yonsei University | 2026-06-01 |
| A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental Vitiligo (NCT07667569) | Idorsia Pharmaceuticals Ltd. | 2026-06-01 |
| Tirzepatide in the Treatment of Endometrial Cancer (NCT07605247) | Rutgers, The State University of New Jersey | 2026-06-01 |
| Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma (NCT07603349) | Nanfang Hospital, Southern Medical University | 2026-06-01 |
| Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD (NCT05170048) | Evergreen Therapeutics, Inc. | 2026-06-01 |
| PSMA-specific CAR-T Cell Therapy (NCT04429451) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases (NCT07539753) | Nanfang Hospital, Southern Medical University | 2026-06-01 |
| RESvEraTrol in Parkinson's Disease (RESET) (NCT07592767) | Georgetown University | 2026-06-01 |
| FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases. (NCT07515963) | Zhongnan Hospital | 2026-06-01 |
| Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors (NCT07612137) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-06-01 |
| HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV (NCT03351855) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Lorigerlimab (MGD019) in Patients With Pancreatic Adenocarcinoma and Homologous Recombination Deficiency (NCT07565155) | Peter Hosein, MD | 2026-06-01 |
| A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) (NCT07621237) | Tonix Pharmaceuticals, Inc. | 2026-06-01 |
| Clinical Study on the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Nab-Paclitaxel in Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma (NCT07493993) | Tianjin Medical University Cancer Institute and Hospital | 2026-06-01 |
| Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes (NCT07608978) | The First Affiliated Hospital with Nanjing Medical University | 2026-06-01 |
| SKB118 Injection in Advanced Solid Tumors (NCT07586943) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-06-01 |
| A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma (NCT07612787) | Centre Hospitalier Universitaire de Saint Etienne | 2026-06-01 |
| A Study of SRSD384 in Overweight or Obese Participants (NCT07557355) | Sirius Therapeutics Co., Ltd. | 2026-06-01 |
| Multi-4SCAR-T Therapy Targeting Breast Cancer (NCT04430595) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| A Clinical Trial of Olutasidenib in Patients With Acute Myeloid Leukemia (NCT07604064) | Kissei Pharmaceutical Co., Ltd. | 2026-06-01 |
| Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery (NCT03244072) | Jason Ahee, M.D. | 2026-06-01 |
| Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma (NCT07547592) | Yonsei University | 2026-06-01 |
| Perioperative Zanidatamab and Chemotherapy for HER2 Positive Gastroesophageal Cancer (NCT07477444) | Universitaire Ziekenhuizen KU Leuven | 2026-06-01 |
| UNC Cashew Sublingual Immunotherapy (NCT07170540) | University of North Carolina, Chapel Hill | 2026-06-01 |
| Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma (NCT07611825) | Jinling Hospital, China | 2026-06-01 |
| CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome (NCT05617625) | Guenther Koehne | 2026-06-01 |
| Cell Therapy for Lower Limb Ulcers in Patients With Critical Limb Ischemia (NCT06326203) | UPECLIN HC FM Botucatu Unesp | 2026-06-01 |
| CLF065 for Chronic Pouchitis (NCT07226050) | Calibr, a division of Scripps Research | 2026-06-01 |
| Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS (NCT04452097) | Baylx Inc. | 2026-06-01 |
| Fecal Microbiota Transplant vs Standard Treatment for Recurrent Non-Obstructive Cholangitis (NCT07509346) | Puerta de Hierro University Hospital | 2026-06-01 |
| Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma (NCT07428993) | St. Jude Children's Research Hospital | 2026-06-01 |
| Psilocybin-Assisted Therapy as a Treatment for Depression (NCT07582120) | Washington University School of Medicine | 2026-06-01 |
| Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial (NCT07349771) | Mayo Clinic | 2026-06-01 |
| Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder (NCT07499440) | HB BioTech, LLC | 2026-06-01 |
| Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension (NCT06405555) | Ottawa Heart Institute Research Corporation | 2026-06-01 |
| Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life Study (NCT07309159) | Centre Hospitalier Charles Perrens, Bordeaux | 2026-06-01 |
| Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia (NCT07583992) | National Research Institute of Chinese Medicine, Ministry of Health and Welfare | 2026-06-01 |
| Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial (NCT07527520) | Fudan University | 2026-06-01 |
| Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use (NCT07452146) | University of California, Los Angeles | 2026-06-01 |
| Radiation Treatment of the Prostate That is Specially Adjusted for Each Person (NCT07578519) | AHS Cancer Control Alberta | 2026-06-01 |
| Vertebrobasilar Dolichoectasia Treatment With Sirolimus (NCT07634120) | Huashan Hospital | 2026-06-01 |
| Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma (NCT07460245) | Gruppo Oncologico Italiano di Ricerca Clinica | 2026-06-01 |